These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24383436)
1. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer. Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436 [TBL] [Abstract][Full Text] [Related]
2. Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods. Aly A; Onukwugha E; Woods C; Mullins CD; Kwok Y; Qian Y; Arellano J; Balakumaran A; Hussain A BMC Med Res Methodol; 2015 Aug; 15():65. PubMed ID: 26286392 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans. Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555 [TBL] [Abstract][Full Text] [Related]
4. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage. Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409 [TBL] [Abstract][Full Text] [Related]
5. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973 [TBL] [Abstract][Full Text] [Related]
6. The utility of Medicare claims data for measuring cancer stage. Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641 [TBL] [Abstract][Full Text] [Related]
7. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States). Barzilai DA; Koroukian SM; Neuhauser D; Cooper KD; Rimm AA; Cooper GS Cancer Causes Control; 2004 Mar; 15(2):179-84. PubMed ID: 15017130 [TBL] [Abstract][Full Text] [Related]
8. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184 [TBL] [Abstract][Full Text] [Related]
9. Comparison of SEER Treatment Data With Medicare Claims. Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121 [TBL] [Abstract][Full Text] [Related]
10. Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone. Onukwugha E; Kwok Y; Ciezki JP; Yong C; Plaisant C; Reddy CA; Mullins CD; Seal B; Valderrama A; Hussain A PLoS One; 2017; 12(4):e0175956. PubMed ID: 28419139 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data. Beyrer J; Nelson DR; Sheffield KM; Huang YJ; Ellington T; Hincapie AL Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1465-1479. PubMed ID: 33012044 [TBL] [Abstract][Full Text] [Related]
12. Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648 [TBL] [Abstract][Full Text] [Related]
13. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. Wang K; Sheets NC; Basak R; Chen RC Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Gold HT; Do HT Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533 [TBL] [Abstract][Full Text] [Related]
15. The sensitivity of Medicare claims data for case ascertainment of six common cancers. Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA Med Care; 1999 May; 37(5):436-44. PubMed ID: 10335746 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database. Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406 [TBL] [Abstract][Full Text] [Related]
17. Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data. Gore JL; Wright P; Shih V; Chang NN; Noshad S; Rey GG; Wang S; Narayanan S JCO Clin Cancer Inform; 2024 Sep; 8():e2400073. PubMed ID: 39298694 [TBL] [Abstract][Full Text] [Related]
18. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392 [TBL] [Abstract][Full Text] [Related]
19. Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis. Onukwugha E; Albarmawi H; Sun K; Mullins CD; Aly A; Hussain A Urol Oncol; 2018 Jul; 36(7):340.e23-340.e31. PubMed ID: 29724482 [TBL] [Abstract][Full Text] [Related]
20. An approach to identifying incident breast cancer cases using Medicare claims data. Freeman JL; Zhang D; Freeman DH; Goodwin JS J Clin Epidemiol; 2000 Jun; 53(6):605-14. PubMed ID: 10880779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]